The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
胆固醇摄取调节剂 PCSK9 可促进 APC/KRAS 突变型结直肠癌的发生,并且是该病的治疗靶点
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-31663-z
Chi Chun Wong, Jian-Lin Wu, Fenfen Ji, Wei Kang, Xiqing Bian, Huarong Chen, Lam-Shing Chan, Simson Tsz Yat Luk, Samuel Tong, Jiaying Xu, Qiming Zhou, Dabin Liu, Hao Su, Hongyan Gou, Alvin Ho-Kwan Cheung, Ka Fai To, Zongwei Cai, Jerry W Shay, Jun Yu